Stephen T. Muth

Closest collaborators

The 25 strongest of 44 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

1. Lei Zheng · 12 shared papers, 2017–2024 · strength 1.36
   • Paper Semaphorin 3D promotes pancreatic ductal adenocarcinoma progression and metastasis through macrophage reprogramming. DOI 10.1126/sciadv.adp0684↗
   • Paper CD137 agonist-based combination immunotherapy enhances activated, effector memory T cells and prolongs survival in panc… DOI 10.1016/j.canlet.2020.11.041↗
   • Paper Preclinical mouse models for immunotherapeutic and non-immunotherapeutic drug development for pancreatic ductal adenoca… DOI 10.21037/apc.2020.03.03↗
2. Kenji Fujiwara · 5 shared papers, 2020–2024 · strength 0.65
   • Paper Semaphorin 3D promotes pancreatic ductal adenocarcinoma progression and metastasis through macrophage reprogramming. DOI 10.1126/sciadv.adp0684↗
   • Paper Direct identification of HLA class I and class II-restricted T cell epitopes in pancreatic cancer tissues by mass spect… DOI 10.1186/s13045-022-01373-6↗
   • Paper Pancreatic cancer cells render tumor-associated macrophages metabolically reprogrammed by a GARP and DNA methylation-me… DOI 10.1038/s41392-021-00769-z↗
3. May Tun Saung · 5 shared papers, 2018–2022 · strength 0.53
   • Paper CD137 agonist-based combination immunotherapy enhances activated, effector memory T cells and prolongs survival in panc… DOI 10.1016/j.canlet.2020.11.041↗
   • Paper CCR2/CCR5 inhibitor permits the radiation-induced effector T cell infiltration in pancreatic adenocarcinoma. DOI 10.1084/jem.20211631↗
   • Paper Interrogating the immune-modulating roles of radiation therapy for a rational combination with immune-checkpoint inhibi… DOI 10.1136/jitc-2019-000351↗
4. Alex B. Blair · 5 shared papers, 2018–2021 · strength 0.52
   • Paper CD137 agonist-based combination immunotherapy enhances activated, effector memory T cells and prolongs survival in panc… DOI 10.1016/j.canlet.2020.11.041↗
   • Paper IDO1 inhibition potentiates vaccine-induced immunity against pancreatic adenocarcinoma. DOI 10.1172/jci124077↗
   • Paper Interrogating the immune-modulating roles of radiation therapy for a rational combination with immune-checkpoint inhibi… DOI 10.1136/jitc-2019-000351↗
5. Elizabeth M. Jaffee · 5 shared papers, 2017–2024 · strength 0.50
   • Paper Semaphorin 3D promotes pancreatic ductal adenocarcinoma progression and metastasis through macrophage reprogramming. DOI 10.1126/sciadv.adp0684↗
   • Paper Hedgehog signaling stimulates Tenascin C to promote invasion of pancreatic ductal adenocarcinoma cells through Annexin … DOI 10.1080/19336918.2016.1259057↗
   • Paper Dissecting the Stromal Signaling and Regulation of Myeloid Cells and Memory Effector T Cells in Pancreatic Cancer. DOI 10.1158/1078-0432.ccr-18-4192↗
6. Keyu Li · 4 shared papers, 2020–2024 · strength 0.49
   • Paper Semaphorin 3D promotes pancreatic ductal adenocarcinoma progression and metastasis through macrophage reprogramming. DOI 10.1126/sciadv.adp0684↗
   • Paper Anti-IL-8 antibody activates myeloid cells and potentiates the anti-tumor activity of anti-PD-1 antibody in the humaniz… DOI 10.1016/j.canlet.2022.215722↗
   • Paper CCR2/CCR5 inhibitor permits the radiation-induced effector T cell infiltration in pancreatic adenocarcinoma. DOI 10.1084/jem.20211631↗
7. Brian T. Herbst · 4 shared papers, 2020–2022 · strength 0.48
   • Paper Direct identification of HLA class I and class II-restricted T cell epitopes in pancreatic cancer tissues by mass spect… DOI 10.1186/s13045-022-01373-6↗
   • Paper Anti-IL-8 antibody activates myeloid cells and potentiates the anti-tumor activity of anti-PD-1 antibody in the humaniz… DOI 10.1016/j.canlet.2022.215722↗
   • Paper CCR2/CCR5 inhibitor permits the radiation-induced effector T cell infiltration in pancreatic adenocarcinoma. DOI 10.1084/jem.20211631↗
8. Nan Niu · 3 shared papers, 2022 · strength 0.40
   • Paper Direct identification of HLA class I and class II-restricted T cell epitopes in pancreatic cancer tissues by mass spect… DOI 10.1186/s13045-022-01373-6↗
   • Paper Anti-IL-8 antibody activates myeloid cells and potentiates the anti-tumor activity of anti-PD-1 antibody in the humaniz… DOI 10.1016/j.canlet.2022.215722↗
   • Paper CCR2/CCR5 inhibitor permits the radiation-induced effector T cell infiltration in pancreatic adenocarcinoma. DOI 10.1084/jem.20211631↗
9. Xingyi Pan · 2 shared papers, 2021–2024 · strength 0.29
   • Paper Semaphorin 3D promotes pancreatic ductal adenocarcinoma progression and metastasis through macrophage reprogramming. DOI 10.1126/sciadv.adp0684↗
   • Paper Pancreatic cancer cells render tumor-associated macrophages metabolically reprogrammed by a GARP and DNA methylation-me… DOI 10.1038/s41392-021-00769-z↗
10. Ding Ding · 3 shared papers, 2018–2022 · strength 0.29
    • Paper CCR2/CCR5 inhibitor permits the radiation-induced effector T cell infiltration in pancreatic adenocarcinoma. DOI 10.1084/jem.20211631↗
    • Paper Interrogating the immune-modulating roles of radiation therapy for a rational combination with immune-checkpoint inhibi… DOI 10.1136/jitc-2019-000351↗
    • Paper Targeting myeloid-inflamed tumor with anti-CSF-1R antibody expands CD137+ effector T-cells in the murine model of pancr… DOI 10.1186/s40425-018-0435-6↗
11. Adrian Gerard Murphy · 2 shared papers, 2019–2020 · strength 0.25
    • Paper Preclinical mouse models for immunotherapeutic and non-immunotherapeutic drug development for pancreatic ductal adenoca… DOI 10.21037/apc.2020.03.03↗
    • Paper IDO1 inhibition potentiates vaccine-induced immunity against pancreatic adenocarcinoma. DOI 10.1172/jci124077↗
12. Noah S Rozich · 2 shared papers, 2022 · strength 0.24
    • Paper Anti-IL-8 antibody activates myeloid cells and potentiates the anti-tumor activity of anti-PD-1 antibody in the humaniz… DOI 10.1016/j.canlet.2022.215722↗
    • Paper CCR2/CCR5 inhibitor permits the radiation-induced effector T cell infiltration in pancreatic adenocarcinoma. DOI 10.1084/jem.20211631↗
13. Yao Xu · 2 shared papers, 2022 · strength 0.24
    • Paper Anti-IL-8 antibody activates myeloid cells and potentiates the anti-tumor activity of anti-PD-1 antibody in the humaniz… DOI 10.1016/j.canlet.2022.215722↗
    • Paper CCR2/CCR5 inhibitor permits the radiation-induced effector T cell infiltration in pancreatic adenocarcinoma. DOI 10.1084/jem.20211631↗
14. Noelle R. Jurcak · 2 shared papers, 2020–2021 · strength 0.21
    • Paper Pancreatic cancer cells render tumor-associated macrophages metabolically reprogrammed by a GARP and DNA methylation-me… DOI 10.1038/s41392-021-00769-z↗
    • Paper Interrogating the immune-modulating roles of radiation therapy for a rational combination with immune-checkpoint inhibi… DOI 10.1136/jitc-2019-000351↗
15. Christopher L. Wolfgang · 2 shared papers, 2019–2022 · strength 0.20
    • Paper Anti-IL-8 antibody activates myeloid cells and potentiates the anti-tumor activity of anti-PD-1 antibody in the humaniz… DOI 10.1016/j.canlet.2022.215722↗
    • Paper Dissecting the Stromal Signaling and Regulation of Myeloid Cells and Memory Effector T Cells in Pancreatic Cancer. DOI 10.1158/1078-0432.ccr-18-4192↗
16. Jin Peng He · 2 shared papers, 2019–2022 · strength 0.20
    • Paper CCR2/CCR5 inhibitor permits the radiation-induced effector T cell infiltration in pancreatic adenocarcinoma. DOI 10.1084/jem.20211631↗
    • Paper Dissecting the Stromal Signaling and Regulation of Myeloid Cells and Memory Effector T Cells in Pancreatic Cancer. DOI 10.1158/1078-0432.ccr-18-4192↗
17. Qian Xiao · 2 shared papers, 2017–2021 · strength 0.19
    • Paper Pancreatic cancer cells render tumor-associated macrophages metabolically reprogrammed by a GARP and DNA methylation-me… DOI 10.1038/s41392-021-00769-z↗
    • Paper Dual Inhibition of Hedgehog and c-Met Pathways for Pancreatic Cancer Treatment. DOI 10.1158/1535-7163.mct-16-0452↗
18. Xu Che · 2 shared papers, 2017–2021 · strength 0.19
    • Paper Pancreatic cancer cells render tumor-associated macrophages metabolically reprogrammed by a GARP and DNA methylation-me… DOI 10.1038/s41392-021-00769-z↗
    • Paper Dual Inhibition of Hedgehog and c-Met Pathways for Pancreatic Cancer Treatment. DOI 10.1158/1535-7163.mct-16-0452↗
19. Victoria Kim · 2 shared papers, 2019 · strength 0.19
    • Paper IDO1 inhibition potentiates vaccine-induced immunity against pancreatic adenocarcinoma. DOI 10.1172/jci124077↗
    • Paper Dissecting the Stromal Signaling and Regulation of Myeloid Cells and Memory Effector T Cells in Pancreatic Cancer. DOI 10.1158/1078-0432.ccr-18-4192↗
20. Wei‐Chih Sun · 1 shared paper, 2024 · strength 0.17
    • Paper Semaphorin 3D promotes pancreatic ductal adenocarcinoma progression and metastasis through macrophage reprogramming. DOI 10.1126/sciadv.adp0684↗
21. Selina Shiqing K. Teh · 1 shared paper, 2024 · strength 0.17
    • Paper Semaphorin 3D promotes pancreatic ductal adenocarcinoma progression and metastasis through macrophage reprogramming. DOI 10.1126/sciadv.adp0684↗
22. Noelle R. J. Thielman · 1 shared paper, 2024 · strength 0.17
    • Paper Semaphorin 3D promotes pancreatic ductal adenocarcinoma progression and metastasis through macrophage reprogramming. DOI 10.1126/sciadv.adp0684↗
23. Lisa M. Coussens · 2 shared papers, 2018–2019 · strength 0.16
    • Paper Dissecting the Stromal Signaling and Regulation of Myeloid Cells and Memory Effector T Cells in Pancreatic Cancer. DOI 10.1158/1078-0432.ccr-18-4192↗
    • Paper Targeting myeloid-inflamed tumor with anti-CSF-1R antibody expands CD137+ effector T-cells in the murine model of pancr… DOI 10.1186/s40425-018-0435-6↗
24. Takahiro Tsujikawa · 2 shared papers, 2018–2019 · strength 0.16
    • Paper Dissecting the Stromal Signaling and Regulation of Myeloid Cells and Memory Effector T Cells in Pancreatic Cancer. DOI 10.1158/1078-0432.ccr-18-4192↗
    • Paper Targeting myeloid-inflamed tumor with anti-CSF-1R antibody expands CD137+ effector T-cells in the murine model of pancr… DOI 10.1186/s40425-018-0435-6↗
25. Lei Zheng · 1 shared paper, 2022 · strength 0.16
    • Paper Direct identification of HLA class I and class II-restricted T cell epitopes in pancreatic cancer tissues by mass spect… DOI 10.1186/s13045-022-01373-6↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.